Programmed Droplet Rupture for Directed Evolution Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current directed evolution screening methods face limitations in compatibility with both in vivo and in vitro platforms, throughput, scalability, and broad applicability, particularly in evolving gene circuits, metabolic production, and protein expression regulation.
Innovation Solution
A method involving selecting a protein expression platform, expressing a key rupture gene to trigger droplet rupture, developing gene regulatory circuits to control the rupture gene's expression based on the evolution target's performance, and encapsulating expression components in droplets for controlled rupture, enabling both positive and negative selection strategies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If traditional binding assays are used for directed evolution screening, then the method is simple to implement, but it is limited to evolving binding reagents only
Solution Approach 1:
The droplet-based screening platform uses a universal droplet encapsulation system that can accommodate multiple types of evolution targets (gene circuits, metabolic pathways, binding reagents, protein expression systems) through a single standardized interface, allowing one system to perform multiple screening functions
2Adaptability or versatility
If fluorescent or pigment protein expression methods are used, then a wider range of applications is possible, but the methods are limited to either in vivo or in vitro use and suffer from throughput or scalability issues
Solution Approach 1:
The system segments the screening process into individual droplet units, each containing a single mutant and its expression components. This segmentation enables parallel processing of thousands of mutants simultaneously while maintaining control over each individual reaction, achieving both high throughput and scalability
Solution Approach 2:
The patent introduces an intermediary signaling system where the evolution target's performance is transduced into a measurable output signal (such as fluorescence or color change) that can be detected in the droplet assay, bridging the gap between diverse biological functions and a unified screening readout
3Adaptability or versatility
If other screening methods involving fluorescent proteins or enzyme substrates are used, then various applications can be addressed, but they lack broad applicability across in vivo and in vitro platforms
Solution Approach 1:
The droplet encapsulation platform provides a universal system that works with both in vivo (whole cells) and in vitro (cell-free) expression systems through the same basic assay format, eliminating the need for platform-specific optimization
Data Source
AI summary
A method of directed evolution screening includes selecting a protein expression platform for an evolution target, expressing a key rupture gene configured to trigger droplet rupture, developing gene regulatory circuits to control expression of the key rupture gene as a function of performance of the evolution target, encapsulating expression components in droplets, and triggering droplet rupture by expressing a rupture agent from the key rupture gene.